Aperçu des produits pour anti-Myogenic Differentiation 1 (MYOD1) Anticorps

Full name:
anti-Myogenic Differentiation 1 Anticorps (MYOD1)
Chez www.anticorps-enligne.fr sont 263 Myogenic Differentiation 1 (MYOD1) Anticorps de 26 de différents fournisseurs disponibles. De plus, nous expédions Myogenic Differentiation 1 Kits (17) et Myogenic Differentiation 1 Protéines (10) et beaucoup plus de produits pour cette protéine. Un total de 295 Myogenic Differentiation 1 produits sont actuellement listés.
AI503393, bHLHc1, etID309723.25, mf25, MUF3, MYF3, myod, Myod-1, myod1, PUM, wu:fb57a01, XMyoD, XtmyoD, zgc:136744

Tous anti-Myogenic Differentiation 1 Anticorps disponible

Vous arrivez à notre recherche pré-filtrée.

anti-Myogenic Differentiation 1 Anticorps mieux référencés

  1. Cat (Feline) Monoclonal MYOD1 Primary Antibody pour ICC, IF - ABIN4337151 : Sun, Ge, Drnevich, Zhao, Band, Chen: Mammalian target of rapamycin regulates miRNA-1 and follistatin in skeletal myogenesis. dans The Journal of cell biology 2010 (PubMed)
    Show all 7 references for 4337151

  2. Chicken Monoclonal MYOD1 Primary Antibody pour EIA, IHC (fro) - ABIN272324 : Thulasi, Dias, Houghton, Houghton: Alpha 2a-interferon-induced differentiation of human alveolar rhabdomyosarcoma cells: correlation with down-regulation of the insulin-like growth factor type I receptor. dans Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1997 (PubMed)
    Show all 7 references for 272324

  3. Chicken Monoclonal MYOD1 Primary Antibody pour IHC (fro), WB - ABIN967403 : Davis, Weintraub, Lassar: Expression of a single transfected cDNA converts fibroblasts to myoblasts. dans Cell 1988 (PubMed)
    Show all 5 references for 967403

  4. Human Monoclonal MYOD1 Primary Antibody pour ELISA, WB - ABIN969305 : Mal: Histone methyltransferase Suv39h1 represses MyoD-stimulated myogenic differentiation. dans The EMBO journal 2006 (PubMed)
    Show all 3 references for 969305

  5. Human Polyclonal MYOD1 Primary Antibody pour WB - ABIN196752 : Reynaud, Leibovitch, Tintignac, Pelpel, Guillier, Leibovitch: Stabilization of MyoD by direct binding to p57(Kip2). dans The Journal of biological chemistry 2000 (PubMed)
    Show all 3 references for 196752

  6. Human Polyclonal MYOD1 Primary Antibody pour WB - ABIN197309 : Tintignac, Sirri, Leibovitch, Lécluse, Castedo, Metivier, Kroemer, Leibovitch: Mutant MyoD lacking Cdc2 phosphorylation sites delays M-phase entry. dans Molecular and cellular biology 2004 (PubMed)
    Show all 3 references for 197309

  7. Human Polyclonal MYOD1 Primary Antibody pour IF (cc), IF (p) - ABIN740340 : Gong, Zhao, Yang, Li, Chen, Chen, Zhou: The control of mesenchymal stem cell differentiation using dynamically tunable surface microgrooves. dans Advanced healthcare materials 2014 (PubMed)
    Show all 3 references for 740340

  8. Human Polyclonal MYOD1 Primary Antibody pour WB - ABIN2780432 : Delgado-Olguín, Hernández-Hernández, Salamanca, Recillas-Targa, Coral-Vázquez: Identification of two E-boxes that negatively modulate the activity of MyoD on the alpha-sarcoglycan core promoter. dans Biochimica et biophysica acta 2008 (PubMed)

Plus d’anticorps contre Myogenic Differentiation 1 partenaires d’interaction

Horse (Equine) Myogenic Differentiation 1 (MYOD1) interaction partners

  1. SRF and its cofactor MYOCD (Montrer MYOCD Anticorps) likely contribute to the hypertrophy of peripheral airway smooth muscle observed in equine asthmatic airways, while the remodeling of the central airways is more static or involves different transcription factors.

  2. Equine primary fibroblasts were transformed by lentiviral transduction of equine myogenic differentiation 1 into fusion-competent myoblasts.

Human Myogenic Differentiation 1 (MYOD1) interaction partners

  1. The results strongly suggest that the combination of MYCL plus MYOD1 may promote direct conversion of human fibroblasts into functional myoblasts that could potentially be used for regenerative therapy for muscle diseases and congenital muscle defects.

  2. Analysis of the chromatin status of Cdkn1c (Montrer CDKN1C Anticorps) promoter and KvDMR1 in unresponsive compared to responsive cell types showed that their differential responsiveness to the MyoD-dependent induction of the gene does not involve just their methylation status but, rather, the differential H3 lysine 9 dimethylation at KvDMR1.

  3. Data show that MeCP2 promotes gastric cancer (GC) cell proliferation via FOXF1 (Montrer FOXF1 Anticorps)-mediated Wnt5a (Montrer WNT5A Anticorps)/beta-Catenin (Montrer CTNNB1 Anticorps) signaling pathway, and suppresses GC cell apoptosis through MYOD1-mediated Caspase-3 (Montrer CASP3 Anticorps) signaling pathway.

  4. Our results on Pax7 and MyoD protein expression suggest that proliferation and differentiation of skeletal muscle stem cells are affected in ALS patients, and the myogenic processes cannot overcome the denervation-induced wasting.

  5. The molecular pathogenesis of radiotherapy-induced muscle fibrosis involves the TGF-beta1 (Montrer TGFB1 Anticorps) pathway and its repression of MyoD expression. Our results suggest a correlation between traditional swallow therapy /neuromuscular electrical stimulation combined therapy and the restoration of TGF-beta1 (Montrer TGFB1 Anticorps)/MyoD homeostasis in cervical muscles.

  6. Unmethylated MYOD1 gene is associated with chemoradiation resistance in Invasive Cervical Carcinoma.

  7. We provide the first description of a human phenotype that appears to result from MYOD1 mutation. The presentation with Lethal fetal akinesia deformation sequence is consistent with a large body of data demonstrating that in the mouse, MyoD is a major controller of precursor cell commitment to the myogenic differentiation programme

  8. these results suggest that sarcoma metastasis can be partially controlled through Pax7 (Montrer PAX7 Anticorps)/MyoD-dependent activation of miR (Montrer MLXIP Anticorps)-182 and provide insight into the role that myogenic transcription factors have in sarcoma progression

  9. These observations demonstrated the first time that Wnt3a (Montrer WNT3A Anticorps) can directly activate MyoD expression through targeting cis (Montrer CISH Anticorps)-elements in the DE and the L fragment.

  10. Studies indicate that MyoD occupies multiple promoters that induce the transcription of genes vital for establishing the myogenic fate and is also implicated as a mediator of many chromatin modifying enzymes for their recruitment to myogenic enhancers.

Mouse (Murine) Myogenic Differentiation 1 (MYOD1) interaction partners

  1. Results indicate the importance of integrating histone modifications and MyoD chromatin binding for coordinated gene activation and repression during myogenic differentiation.

  2. Data suggest Tle3 plays role in regulation of MyoD1 function during myogenesis; up-regulation of Tle3 expression suppresses myogenesis; conversely, down-regulation of Tle3 expression promotes myogenesis/cell proliferation; Tle3 interferes with MyoD1 by disrupting association of basic helix-loop-helix domain of MyoD with E proteins. (Tle3 = transducin (Montrer GNAT1 Anticorps)-like enhancer of split 3; MyoD1 = myogenic differentiation protein 1)

  3. significant co-localization of binding sites for MyoD and Six proteins on over a thousand mouse genomic DNA regions, were found.

  4. Through mutational analysis, we derive an optimally active phospho-mutant form of MyoD that has a dramatically enhanced ability to drive myogenic reprogramming in vivo. Mechanistically, this is achieved through increased protein stability and enhanced chromatin association. Therefore, multi-site phospho-regulation of class II bHLH proteins is conserved across cell lineages and germ layers, and manipulation of phosphorylat

  5. results suggest that the miR (Montrer MLXIP Anticorps)-29a-Tet1 (Montrer TET1 Anticorps) pathway upregulates MyoD expression and conversely downregulates Cdk6 (Montrer CDK6 Anticorps) expression

  6. Data show that myoblast determination protein 1 (MyoD) acts partially through microRNA miR (Montrer MLXIP Anticorps)-133 to suppress brown adipocyte cell fate.

  7. This evidence demonstrates that TBP2 (Montrer Tbpl2 Anticorps) does not replace TBP (Montrer TBP Anticorps) during muscle differentiation, as previously proposed, with limiting amounts of TFIID-TBP (Montrer TBP Anticorps) being required to promote muscle-specific (Montrer EIF3K Anticorps) gene expression

  8. established a model in which FHL3 (Montrer FHL3 Anticorps) promotes the expression of MyHC 2a (Montrer MYH2 Anticorps) through CREB (Montrer CREB1 Anticorps)-mediated transcription and inhibits the expression of MyHC (Montrer MYH13 Anticorps) 1/slow by inhibiting MyoD transcription activity during myogenesis

  9. Transcription of the skeletal muscle program is achieved by the expression of MyoD, which binds to the same sites as Myf5 (Montrer MYF5 Anticorps), indicating that each factor regulates distinct steps in gene initiation and transcription at a shared set of binding sites

  10. The large TBP polyQ repeat decreases the association of MyoD with TBP and DNA promoters and causes muscle degeneration in spinocerebellar ataxia 17 transgenic mice.

Pig (Porcine) Myogenic Differentiation 1 (MYOD1) interaction partners

  1. an Enhancer box and a binding site for a cooperative co-activator of MyoD are present in the promoter region of porcine PPARgamma (Montrer PPARG Anticorps).

  2. Of the eight adult pig tissue types that were tested, the expression of Myf5 (Montrer MYF5 Anticorps) and MyoD1 was highest in the muscle tissue.

  3. Single nucleotide polymorphisms in the MYOD1 and GDF8 (Montrer MSTN Anticorps) genes are associated with genetic transcription during myogenesis in pigs.

  4. Therefore, this study demonstrated that the different regulatory adipogenic roles of MSTN (Montrer MSTN Anticorps) in ADSCs and MSCs act by differentially regulating PPARgamma (Montrer PPARG Anticorps) and MyoD expression.

  5. Therefore, the g.489C>T and g.1264C>A SNPs in MYOD1 may be meaningful DNA markers that can be used for improving important porcine economic traits.

  6. The total expression profile of MyoD and Pax7 (Montrer PAX7 Anticorps) genes suggests that higher muscularity in Pietrain pigs is associated with the presence of a greater number of active satellite stem cells compared to other breeds.

  7. Exons and promoters are amplified and sequenced in the 5'UTR (Montrer UTS2R Anticorps) region of this gene.

  8. Relative MYOD1 expression was not different, but MYOG (Montrer MYOG Anticorps) expression was higher in the (ligated-tube)crowded group embryos.

  9. MYOD1 intron 1 DdeI polymorphism was not significantly associated with any meat quality traits tested

Cow (Bovine) Myogenic Differentiation 1 (MYOD1) interaction partners

  1. Transcript abundance for the muscle regulatory gene MYOD1 was lower in animals with more tender beef.

  2. Bos taurus MYF5 (Montrer MYF5 Anticorps) activates MYF5 (Montrer MYF5 Anticorps) and MYOD1 expression in cultured fibroblasts.

  3. results suggest that MyoD and Myf5 (Montrer MYF5 Anticorps) influence the MyHC (Montrer MYH13 Anticorps) isoform expression, although the effects are not decisive in specifying the phenotypes of adult muscles

  4. n conclusion, hypoxia stimulates the proliferation of satellite cells and promotes their myogenic differentiation with MyoD playing an important role

Zebrafish Myogenic Differentiation 1 (MYOD1) interaction partners

  1. Irxl1/Mkx (Montrer MKX Anticorps) can repress myoD expression through direct binding to its promoter and may thus play a negative regulatory role in muscle differentiation.

  2. Myod in turn up-regulates cdkn1c (Montrer CDKN1C Anticorps), thereby providing a positive feedback loop that switches myogenic cells to terminal differentiation

  3. Myf5 (Montrer MYF5 Anticorps) and Myod function independently during cranial myogenesis.

Myogenic Differentiation 1 (MYOD1) profil antigène

Antigen Summary

This gene encodes a nuclear protein that belongs to the basic helix-loop-helix family of transcription factors and the myogenic factors subfamily. It regulates muscle cell differentiation by inducing cell cycle arrest, a prerequisite for myogenic initiation. The protein is also involved in muscle regeneration. It activates its own transcription which may stabilize commitment to myogenesis.

Alternative names and synonyms associated with Myogenic Differentiation 1 (MYOD1)

  • myogenic differentiation 1 (myod1) anticorps
  • myogenic differentiation 1 (MYOD1) anticorps
  • myoblast determination protein 1 (myod1) anticorps
  • MYOD protein (myod) anticorps
  • myogenic factor MyoD1 (MyoD1) anticorps
  • myogenic differentiation 1 (Myod1) anticorps
  • AI503393 anticorps
  • bHLHc1 anticorps
  • etID309723.25 anticorps
  • mf25 anticorps
  • MUF3 anticorps
  • MYF3 anticorps
  • myod anticorps
  • Myod-1 anticorps
  • myod1 anticorps
  • PUM anticorps
  • wu:fb57a01 anticorps
  • XMyoD anticorps
  • XtmyoD anticorps
  • zgc:136744 anticorps

Protein level used designations for MYOD1

myogenic factor 3 , myogenic differentiation 1 , MyoD , myoblast determination protein 1 , MYOD protein , myogenic factor MyoD1 , MYOD1 homolog , myoblast determination protein 1 homolog , myogenic factor 1 , class C basic helix-loop-helix protein 1 , myf-3 , myogenic regulatory factor , myogenic differenciation 1, transcription activator , myogenic differenciation 1 , myoblast determination 1

394569 Xenopus (Silurana) tropicalis
451057 Pan troglodytes
611940 Canis lupus familiaris
696222 Macaca mulatta
100071803 Equus caballus
100303674 Meleagris gallopavo
100136534 Salmo salar
100136773 Oncorhynchus mykiss
100534488 Oreochromis niloticus
374048 Gallus gallus
4654 Homo sapiens
17927 Mus musculus
337868 Rattus norvegicus
101097667 Felis catus
407604 Sus scrofa
281938 Bos taurus
443405 Ovis aries
30513 Danio rerio
Fournisseurs de qualité sélectionnés pour anti-Myogenic Differentiation 1 (MYOD1) Anticorps
Avez-vous cherché autre chose?